As of 2024-12-13, the EV/EBITDA ratio of Midatech Pharma PLC (MTPH.L) is 0.70. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. MTPH.L's latest enterprise value is -4.65 mil GBP. MTPH.L's TTM EBITDA according to its financial statements is -6.59 mil GBP. Dividing these 2 quantities gives us the above MTPH.L EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 11.9x - 12.5x | 12.2x |
| Forward P/E multiples | 19.9x - 28.5x | 24.2x |
| Fair Price | (442.54) - (270.49) | (403.02) |
| Upside | -11901.1% - -7313.1% | -10847.1% |
| Date | EV/EBITDA |